Research is underway about how the microbiome develops in children. Research suggests that babies born vaginally have different microbiomes compared to babies born via caesarean section (C-section). This article focuses on ways to promote microbiome development in children, describing when there is good research evidence (such as breastfeeding) and when we don’t yet have enough research evidence (such as fecal matter transfers and vaginal seeding procedures).
Read More »Tag: antibiotics
Is Fetroja a Good Choice for Treating Complicated Urinary Tract Infections (cUTI)?
Fetroja is a new antibiotic to treat complicated urinary tract infections (cUTI). However, we have concerns about the drug because FDA approval was based on two clinical trials that raised questions about safety and effectiveness that were not answered.
Read More »NCHR Testimony at FDA’s Limited Population Pathway for Antimicrobials & Antifungals Meeting
July 12, 2019. There is broad agreement that there is a need to develop new antimicrobials to treat serious or life-threatening infections, however we have serious concerns about FDA’s draft guidance describing the Limited Population Pathway (LPAD).
Read More »Some Antibiotics are Riskier than Others: What You Should Know about Quinolones
There are many different classes of antibiotics, grouped by their pharmacological properties and chemical compounds. While all of the approved antibiotics should be capable of treating bacterial infections, different types are often used to treat different types of infections. This article is focused on the risks and benefits of quinolones.
Read More »